Update on oral lichen planus: etiopathogenesis and management - PubMed (original) (raw)

Review

Update on oral lichen planus: etiopathogenesis and management

C Scully et al. Crit Rev Oral Biol Med. 1998.

Abstract

Lichen planus (LP) is a relatively common disorder of the stratified squamous epithelia, which is, in many ways, an enigma. This paper is the consensus outcome of a workshop held in Switzerland in 1995, involving a selection of clinicians and scientists with an interest in the condition and its management. The oral (OLP) eruptions usually have a distinct clinical morphology and characteristic distribution, but OLP may also present a confusing array of patterns and forms, and other disorders may clinically simulate OLP. Lesions may affect other mucosae and/or skin. Lichen planus is probably of multifactorial origin, sometimes induced by drugs or dental materials, often idiopathic, and with an immunopathogenesis involving T-cells in particular. The etiopathogenesis appears to be complex, with interactions between and among genetic, environmental, and lifestyle factors, but much has now been clarified about the mechanisms involved, and interesting new associations, such as with liver disease, have emerged. The management of lichen planus is still not totally satisfactory, and there is as yet no definitive treatment, but there have been advances in the control of the condition. There is no curative treatment available; immunomodulation, however, can control the condition. Based on the observed increased risk of malignant development, OLP patients should be offered regular follow-up examination from two to four times annually and asked to report any changes in their lesions and/or symptoms. Follow-up may be particularly important in patients with atrophic/ulcerative/erosive affections of the tongue, the gingiva, or the buccal mucosa. Much more research is required into the genetic and environmental aspects of lichen planus, into the premalignant potential, and into the possible associations with chronic liver, and other disorders. More clinical studies are required into the possible efficacy of immunomodulatory drugs such as pentoxifylline and thalidomide.

PubMed Disclaimer

Cited by

FoxP3+CD4+, IFN-γ+CD4+, and IFN-γ+CD8+ cell levels in erosive and non-erosive types of oral lichen planus patients.
Sun A, Wu YH, Chang JY, Wang YP, Chiang CP, Chia JS. Sun A, et al. J Dent Sci. 2021 Mar;16(2):751-756. doi: 10.1016/j.jds.2021.01.005. Epub 2021 Jan 27. J Dent Sci. 2021. PMID: 33854729 Free PMC article.
A retrospective study of 171 patients with oral lichen planus in the East Bohemia - Czech Republic - single center experience.
Radochová V, Dřízhal I, Slezák R. Radochová V, et al. J Clin Exp Dent. 2014 Dec 1;6(5):e556-61. doi: 10.4317/jced.51784. eCollection 2014 Dec. J Clin Exp Dent. 2014. PMID: 25674326 Free PMC article.
A review of research on salivary biomarkers for oral cancer detection.
Cheng YS, Rees T, Wright J. Cheng YS, et al. Clin Transl Med. 2014 Feb 24;3(1):3. doi: 10.1186/2001-1326-3-3. Clin Transl Med. 2014. PMID: 24564868 Free PMC article.
Reticular Oral Lichen Planus: A Clinical Experience of ENT Surgeons.
Patigaroo SA, Ali I, Maqbool T, Qadri H, Showkat SA, Latoo MA. Patigaroo SA, et al. Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):390-396. doi: 10.1007/s12070-022-03267-y. Epub 2022 Nov 10. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37275004 Free PMC article.
Role of Depression, Anxiety and Stress in Patients with Oral Lichen Planus: A Pilot Study.
Kalkur C, Sattur AP, Guttal KS. Kalkur C, et al. Indian J Dermatol. 2015 Sep-Oct;60(5):445-9. doi: 10.4103/0019-5154.159625. Indian J Dermatol. 2015. PMID: 26538689 Free PMC article.

Update on oral lichen planus: etiopathogenesis and management - PubMed (original) (raw)